Scholars Central

Mini reviewPublished 25 Apr 2023

Drug Development in the Age of Biotechnology: Integrating Science and Technology

Authors: Yuhua Zhang

Journal of Bioengineering & Biomedical Science

Volume 13 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The convergence of biotechnology and pharmaceutical sciences has ushered in a new era of drug development, revolutionizing the way we approach the discovery, design, and delivery of medications. Biotechnology, with its profound understanding of living organisms and their molecular processes, has become a driving force behind the development of innovative therapeutics. This paper explores the impact of biotechnology on drug development, focusing on the integration of cutting-edge science and technology to address complex medical challenges. From recombinant DNA technology and monoclonal antibodies to gene therapies and personalized medicine, biotechnology-driven drug development has opened doors to targeted, precise, and patient-centric treatments. This paper delves into the advancements in biotechnology, the challenges faced in this domain, and the potential future directions that hold promise for transforming healthcare through novel drug therapies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioengineering & Biomedical Science.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioengineering & Biomedical Science
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Yuhua Zhang”